Searched for
CELL THERAPY FACILITY
Telangana plans drug discovery push to move Hyderabad up pharma value chainTelangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by...- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 27%, according to analystsWe are in a phase in the US-Israel-Iran war where statements are made, then retracted. And, in a matter of just 48 hours, they are made all...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
- Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
- Tata-backed MedTherapy claims CAR-T breakthrough with one-day productionTata Sons-backed biotech startup MedTherapy said it has developed a next-generation CAR-T cell therapy manufacturing platform that can redu...
- What Chernobyl’s Wolves Learned to Survive That Scientists Still Don’t Fully UnderstandWildlife thrives in Chernobyl's exclusion zone. Grey wolves there show remarkable genetic changes. These wolves have developed resistance t...
- Johnson & Johnson to invest $1 billion in new Pennsylvania plant amid US manufacturing pushIn March, the company announced a plan to invest more than $55 billion through early 2029 to build manufacturing facilities and research ...
- Bharat Biotech invests Rs 600 cr to expand into cell, gene therapiesAs per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...
- Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028Bharat Biotech has invested $75 million in its first cell and gene therapy facility in Telangana, India, aiming to launch new therapies in ...
- Ajay Hinduja on advancing cancer care: Insights on CAR-T therapy innovationIndia has reached a milestone in cancer treatment with the first successful allogeneic CAR-T therapy at P. D. Hinduja Hospital, led by Dr. ...
- East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro LabsEast Ocyon Bio aims to reshape India’s role in the global biotech landscape, creating an ecosystem where pioneering therapies are developed...
- Aurigene reports promising phase-1 data for its CAR-T therapy against myelomaAurigene Oncology has announced promising phase-1 results for its novel CAR-T cell therapy, Ribrecabtagene autoleucel, in patients with mul...
- Laurus Labs invests Rs 80 crore in cell & gene therapy firm ImmunoACTThe fresh infusion of capital will enable ImmunoACT to fast-track the scale-up of its lead candidate HCAR-19 by expansion of the multi-loca...
- US-based StemCures to set up India's largest stem cell manufacturing lab in HyderabadThe announcement was made after Dr Sairam Atluri, Founder, StemCures met with Telangana IT and Industries Minister K T Rama Rao in Boston, ...
- Immuneel Therapeutics raises $15 million in fundingImmuneel Therapeutics is working on developing its own pipeline of chimeric antigen receptor T-cell (CAR-T) therapies and other cellular im...
- Immuneel signs pact with Hospital Clínic de Barcelona to work on cancer therapyThe collaboration opens up opportunities for co-development of advanced assets to be deployed in Spain and India, said Immuneel in a press ...
- Stem cells can't fix all diseases: AIIMSDr Kameshwar Prasad, head of Neurology Department at AIIMS, said stem cell therapy has been shown to be effective only in certain blood dis...
- Stem cell banks grow on hope of healthy dividendStem cell research promises to dramatically change the way diseases are treated, Indians are turning up in large numbers at specialised ‘ba...
- Corporate India bets big on stem cellThe day may not be too far when India may become a global hub for cure to deadly diseases such as cancer, neurology and cardiac problems. B...
Load More
